Research Partners

Amprion values its research partners for their commitment and dedication to science. We stand united on a single mission–finding cures for brain diseases.

We’re known by the company we keep. These research partners joined Amprion on the path of making scientific breakthroughs in neurodegenerative diseases.

National Institute of Neurological Disorders and Stroke (NIH)

National Institute of Aging

National Institutes of Health

Alzheimer’s Drug Discovery Foundation (ADDF)

The Michael J. Fox Foundation logo

The Michael J. Fox Foundation

Please Note: Important Billing Info

To improve patient access to the SYNTap® Biomarker CSF Test, Amprion offers the following billing options:

  • List price of $1500, with courtesy billing for both Medicare and private insurance.
  • An affordable self-pay price of $995 (patients may qualify for financial assistance and/or interest-free payment options).
  • Prices are effective as of January 1, 2024, and are subject to change.

Please note: Amprion is a Medicare participating provider, however, the SYNTap test does not currently have Medicare coverage determination. Also, Amprion is not yet in network with most insurers.

The SYNTap Biomarker CSF Test has been issued a dedicated CPT® PLA code to be used when billing: 0393U.

For additional information, please visit our billing page.